These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

804 related items for PubMed ID: 30369122

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Application of chromosomal microarray in fetuses with increased nuchal translucency.
    Zhao XR, Gao L, Wu Y, Wang YL.
    J Matern Fetal Neonatal Med; 2020 May; 33(10):1749-1754. PubMed ID: 30688128
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Comparison of results of prenatal diagnosis by different techniques for fetuses with increased nuchal translucency].
    Dai W, Liu X, Ma X, Yu Z, Li H.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 May 10; 40(5):532-537. PubMed ID: 37102284
    [Abstract] [Full Text] [Related]

  • 8. Selection of prenatal screening with nuchal translucency > 95th centile and below 99th centile: a 4-year observational study with real-world data.
    Zhang B, Zhang LX, Yi J, Wang CH, Zhao Y.
    Arch Gynecol Obstet; 2024 Sep 10; 310(3):1779-1785. PubMed ID: 38625542
    [Abstract] [Full Text] [Related]

  • 9. [Application of chromosomal microarray analysis in prenatal diagnosis of fetuses with increased nuchal translucency].
    Ni M, Li J, Zhu X, Zhu Y, Gu L, Wu X, Yang Y.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Oct 10; 36(10):970-974. PubMed ID: 31598938
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency.
    Sinajon P, Chitayat D, Roifman M, Wasim S, Carmona S, Ryan G, Noor A, Kolomietz E, Chong K.
    Ultrasound Obstet Gynecol; 2020 Mar 10; 55(3):383-390. PubMed ID: 31115076
    [Abstract] [Full Text] [Related]

  • 14. [Clinical value of genome-wide high resolution chromosomal microarray analysis in etiological study of fetuses with congenital heart defects].
    Wu X, Fu F, Li R, Pan M, Han J, Zhen L, Yang X, Zhang Y, Li F, Liao C.
    Zhonghua Fu Chan Ke Za Zhi; 2014 Dec 10; 49(12):893-8. PubMed ID: 25608988
    [Abstract] [Full Text] [Related]

  • 15. [Clinical features of abnormal chromosome karyotypes in twin pregnancies complicated with structural abnormalities].
    Zhong SL, Fang Q, Chen BJ, Han ZY, Luo YM, Chen JS, Xie YJ.
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep 10; 46(9):649-54. PubMed ID: 22176987
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. What would be missed in the first trimester if nuchal translucency measurement is replaced by cell free DNA foetal aneuploidy screening?
    Huang LY, Pan M, Han J, Zhen L, Yang X, Li DZ.
    J Obstet Gynaecol; 2018 May 10; 38(4):498-501. PubMed ID: 29433355
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X, Chang Y, Cui HY, Ren CC, Yu BY.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov 10; 48(11):815-8. PubMed ID: 24444556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.